<DOC>
	<DOC>NCT00333021</DOC>
	<brief_summary>This study is phase 3 study for prevention of VTE in patients with abdominal surgery.</brief_summary>
	<brief_title>Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patients</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Fondaparinux</mesh_term>
	<mesh_term>PENTA</mesh_term>
	<criteria>Inclusion criteria: Patients aged &gt;=40 years undergoing the following abdominal (diaphragm to pelvic floor) surgery under general anesthesia lasting more than 45 minutes. General or urologic surgery Cancer surgery Gynecologic surgery Radical surgery for pelvic malignancy Exclusion criteria: Active, clinically significant bleeding Thrombocytopenia Body weight &lt;40kg</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Fondaparinux Abdominal surgery Japanese VTE</keyword>
</DOC>